Chinese company Hengrui gains after R&D revenues for novel drugs boosted first-half profits
(Yicai) August 22 – Hengrui Pharmaceuticals shares rose after the leading Chinese pharmaceutical company announced that profits and sales rose sharply in the first half of the year, further reversing the profit slump of recent years thanks to the company’s investments in innovative drugs. Hengrui (SHA: 600276) closed 3.8 percent higher at CNY 43.93 (USD […]
